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Background
SJS-TENs pathogenesis is not completely explained and its
immunological symptoms are similar to graft versus host
disease so; it is possible to say that SJS-TEN is a disorder
of the cell-mediated immunity. We report a first case of
patient with intracranial tumors who developed a
cutaneous adverse drug reaction during lansoprazole and
prophylactic anticonvulsants treatment.
Methods
Our patient is a 64 year-old female, who had glioma and
had been on post-op anticonvulsants therapy. On the 3rd
day after she had an operation, lansoprazole was added to
the therapy. After the first lansoprazole dose erythematous
dusky red macules were occured in extremities and trunk
and on the following day confluent purpuric lesions
tended to run together in 95% of the whole body including
scalp and, oral and genital mucosa. Nikolsky’s Sign was
positive on the skin. Body temparature was 38.4°C with
heart rate of 146beats/min. GlascowComaScale was
E1M1e, pupillary light reflex was 2/2+/+. SCORTEN was
calculated as 5 and her biopsy resulted as TEN.
Results
As a treatment, firstly fluid and electrolyte homeostasis
and skin lesions were maintained. For daily nutritional
requirements total parenteral nutrition was supplied.
Human albumin and IVIG in dose of 400mg/kg were
usedand pulse steroid therapy. She was discharged from
the hospital on the 23rd day and followed in the clinical
immunology unit after 2 months.
Conclusions
On six day intensive care unit serum STRAIL level was
302 pg/mL and in blister fluid soluble TRAIL level was
603 pg/mL. Two months after dischange serum soluble
TRAIL level was 546 pg/mL. We found that the amounts
of soluble TRAIL were higher in TEN blister fluids than in
serum at the same time and after two months. TRAIL and
TWEAK were secreted by CD1a+ and CD14+ cells
present in the blister fluids we studied.This result suggest
that TRAIL could also be a mediators of keratinocyte cell
death in SJS-TEN.
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